相关实验视频
Updated: Sep 10, 2025

07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.7K
11种常见的固体癌症的DNA甲基化单体图
Zhiqiang Zhang1, Yuyang Hong2, Shirong Zhang3
1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200030, China.
Cell reports
|August 24, 2025
概括
甲基化单元型阻断 (MHBs) 是11种癌症的新型表观遗传标记. 这些块为基因表达,瘤异质性提供了洞察力,并作为癌症检测的有效生物标志物.
科学领域:
- 基因组学
- 表观遗传学
- 癌症生物学
背景情况:
- 异质瘤在相邻的CpG位点表现出甲基化单元型块 (MHBs),反映出局部表观遗传一致性.
- 在基因失调中MHBs的泛癌动态和临床意义尚未完全理解.
研究的目的:
- 为了调查MHBs的泛癌风景.
- 探索MHB与基因表达和瘤异质性的关联.
- 评估MHB作为癌症检测的潜在生物标志物.
主要方法:
- 在11种常见的固体癌症中分析了110种原发性瘤.
- 标识和描述81567个MHB.
- 综合性批量和单细胞分析,以将MHB与基因表达联系起来.
- 与驱动突变和炎症途径相关的MHB异常的分析.
主要成果:
- MHB 具有较高的癌症特异性和监管元素的丰富性.
- MHB与基因表达独立于平均甲基化变化.
- 与MHB相关的基因涉及关键的致癌途径 (G2/M检查点,MYC目标,E2F信号传递).
- MHB异调与驱动突变和炎症途径相关.
- 作为癌症检测的有效生物标志物,
结论:
- MHBs是影响转录控制和瘤异质性的多模式表观遗传调节剂.
- MHBs是了解癌症表观遗传学的宝贵资源.
- 液体活检具有促进液体活检诊断和癌症检测的潜力.
相关概念视频
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K

